other material
confidence high
sentiment neutral
materiality 0.55
NKGen Biotech amends forward purchase agreement, sets floor price at $1.2743 and allows 248,360 additional shares
NKGen Biotech, Inc.
- Second amendment to OTC equity prepaid forward transaction with Sandia Investment Management LP dated April 18, 2024.
- Reset price floor set at $1.2743; weekly adjustment formula revised to 90% of prior week VWAP but not below floor.
- Seller may deliver notice for up to 248,360 additional shares under the confirmation, subject to applicable share limit.
- NKGen acknowledges non-public information possession; Seller waives claims related to material non-public information.